AHK-Cu
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
AHK-Cu is a synthetic copper-binding tripeptide made of three amino acids — alanine, histidine, and lysine — complexed with a copper ion. It is structurally a close cousin of GHK-Cu, the naturally occurring copper tripeptide, differing by only the first amino acid, and is often marketed under the cosmetic name copper tripeptide-3.
It is most commonly discussed in the context of hair and scalp care, where it has been studied for effects on the dermal papilla cells that sit at the base of the hair follicle and help govern hair growth. It is also grouped with other copper peptides for its reported role in skin support.
Much of the available evidence comes from laboratory and cell-culture work rather than large human trials. AHK-Cu is not approved by any major regulator for a therapeutic use, and is typically sold as a topical cosmetic or research-only ingredient.
How it works
Copper peptides act in part as carriers for copper, a trace element involved in enzymatic reactions tied to collagen formation and tissue repair. In a widely cited in vitro study, AHK-Cu stimulated the proliferation of cultured dermal papilla cells and the elongation of human hair follicles ex vivo, while shifting cell-survival markers away from programmed cell death (apoptosis).
Researchers have also reported that copper tripeptides can increase vascular endothelial growth factor (VEGF), which supports blood-vessel formation, and modulate transforming growth factor-beta (TGF-β) signaling in dermal fibroblasts. The precise mechanism and its relevance to outcomes in humans are not established.
Reported benefits
- Support for hair follicle growth and dermal papilla cell activity (laboratory data)
- Reported support for skin regeneration and fibroblast activity, in line with other copper peptides
- Studied for effects on growth-factor signaling (VEGF, TGF-β) in cell models
These are reported and studied effects from early research, not guaranteed outcomes.
Considerations & side effects
Human clinical data on AHK-Cu is limited, so its long-term safety and effectiveness are not well characterized. As a topical copper peptide, commonly reported considerations include local skin or scalp irritation, and the general caution that copper-containing formulations may interact with certain other active ingredients.
Product purity and concentration vary widely across the cosmetic and research-chemical market. AHK-Cu is not a substitute for evaluation and treatment by a qualified clinician.
Frequently asked
What is AHK-Cu?
A synthetic copper-binding tripeptide (alanine-histidine-lysine bound to copper), studied primarily for hair follicle and skin applications. It is closely related to the naturally occurring copper tripeptide GHK-Cu, differing by a single amino acid.
Is AHK-Cu FDA-approved?
No. AHK-Cu is not approved by the FDA or any major regulator for a therapeutic indication. It is sold as a cosmetic or research-only ingredient.
How is AHK-Cu typically used?
It is most commonly discussed as a topical ingredient in serums and scalp formulations rather than an injectable.
How strong is the evidence for AHK-Cu?
Evidence is early. The most-cited work is a laboratory (in vitro / ex vivo) study on cultured cells and hair follicles; controlled human clinical trials are limited.
References
Related compounds
Copper peptide with regenerative properties. Supports skin health, wound healing, and hair growth.
Multi-peptide skin rejuvenation blend combining GHK-Cu, TB-500, and BPC-157 in a 5:1:1 ratio. Promotes skin regeneration, collagen synthesis, and tissue healing. Sold as a single pre-mixed vial.
Tripeptide derived from alpha-MSH with potent anti-inflammatory properties. Targets gut health, immune modulation, and inflammatory skin conditions.